study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
MENT-LAV-CAPS_01,2006,randomized controlled trial,SMD,-0.2825,-0.4205,-0.1445,56,53,some concerns,10.1234/ment-lav-caps-01,mental_health_journal,anxiety,Adults with anxiety concerns,Mild GI discomfort,10
MENT-LAV-CAPS_02,2007,randomized controlled trial,SMD,-0.3461,-0.4793,-0.2129,60,56,mixed,10.1234/ment-lav-caps-02,mental_health_journal,anxiety,Adults with anxiety concerns,Transient headache,11
MENT-LAV-CAPS_03,2008,randomized controlled trial,SMD,-0.4028,-0.5341,-0.2715,64,59,low,10.1234/ment-lav-caps-03,mental_health_journal,anxiety,Adults with anxiety concerns,None reported,6
